Document is current
Any future updates will be listed below
-
Authors
Chimukuche, Rujeko Samanthia http://orcid.org/0000-0002-4890-2105
Kawuma, Rachel http://orcid.org/0000-0001-5338-3517
Mahapa, Nteboheleng
Mkhwanazi, Smanga
Singh, Nishanta
Siva, Samantha
Ruzagira, Eugene http://orcid.org/0000-0002-7291-1693
Seeley, Janet http://orcid.org/0000-0002-0583-5272
,
Gray, Glenda
Singh, Nishanta
Gaffoor, Zakir
Morar, Neetha
Sithole, Thandiwe
Woeber, Kubashni
Siva, Samantha
Hwengwere, Eldinah
Chidawanyika, Rujeko Samanthia
Mahapa, Nteboheleng
Khanyile, Phindile
Jani, Ilesh
Viegas, Edna
Remane, Isabel
Bule, Odete
Nhacule, Edna
Ramgi, Patricia
Chissumba, Raquel
Namalango, Eduardo
Manganhe, Yolanda
Massingue, Carmelia
Capitine, Igor
Ribeiro, Jorge
Maganga, Lucas
William, Wiston
Kapesa, Emmanuel
Danstan, Elizabeth
Pamba, Doreen
Kway, Marco Missanga Amani
Kisinda, Abisai
Njovu, Lilian
Sudi, Lwitiho
Kunambi, Revocatus
Aboud, Said
Munseri, Patricia
Lyamuya, Eligius
Msafiri, Frank
Joachim, Agricola
Tarimo, Edith
Nagu, Diana Faini Tumaini
Buma, Deus
Bakari, Muhammad
Kaleebu, Pontiano
Kibengo, Freddie Mukasa
Kakande, Ayoub
Serwanga, Jennifer
Kawuma, Rachel
Holmes, Christian Hansen
Kansiime, Sheila
Ruzagira, Eugene
Seeley, Janet
Kusemererwa, Sylvia
Masawi, Sylvia
Basajja, Vincent
Vudriko, Tobias
Hughes, Peter
Nabukenya, Shamim
Mutonyi, Gertrude
Nakiboneka, Rita
Mugaba, Susan
Weber, Jonathan
Kingsley, Cherry
Miller, Tom
McCormack, Sheena
Crook, Angela
Dunn, David
Bern, Henry
Sy, Aminata
Brodnicki, Liz
Joseph, Sarah
Wenden, Claire
Chinyenze, Kundai
Musau, Jacqueline
Matsoso, Mabela
Amondi, Mary
Chetty, Paramesh
Gumbe, Anne
Pantaleo, Giuseppe
Ding, Song
Nilsson, Charlotta
Kroidl, Arne
Fox, Julie
Doncel, Gustavo
Matthews, Allison
Rooney, Jim
Lee, Carter
Robb, Merlin
- License Information
-
More Information
Article History
Received: 8 November 2021
Accepted: 26 October 2022
First Online: 10 November 2022
Declarations
:
: Approval to conduct the HIV vaccine trial preparedness study was obtained from the South African Medical Research Council Ethics Committee (Reference number: EC004-5/2018). All methods were performed in accordance with the relevant guidelines and regulations. Written informed consent to participate in all study procedures including the qualitative interviews was obtained at enrolment into the HIV vaccine trial preparedness study. At the beginning of each interview the purpose of the study was explained, and the participant asked if they had any questions. To ensure confidentiality, interviews were conducted in private rooms and names or personal identifiers were not used in the transcripts. Access to data was restricted to authorised study staff.
: N/A
: N/A
